Director, Biostatistics at Celcuity — USA | Base Career

Full Job Posting

Reporting to the Vice President, Biostatistics and Data Management, the Director, Biostatistics will focus on actively contributing to efforts across multiple studies, analyzing and reporting on any or all parts of clinical studies.

The role will have oversight of statistical programming and deliverables that contribute to the quality assurance and control of statistical analyses, writing methods and analysis descriptions in formal reports, communicating with collaborators, and organizing and maintaining confidential project materials.

Responsibilities

Lead and coordinate statistical related activities to support clinical studies including but not limited to supporting the design, execution, analysis, interpretation, and reporting of clinical trials as well as communication of data evidence.
Support for the statistical aspects of business-critical and/or regulatory commitments, provides input to program plans, and represents the Biostatistics function for cross-functional and intra-departmental teams or working groups.
Prepare or review the clinical study protocols, case report forms, statistical analysis plans, and table shells as needed.
Create or validate SAS programs for data management activities, compliant analysis datasets, and statistical analysis of the clinical trial data.
Prepare the statistical section of clinical trial reports and presentations of the results to the team.
Demonstrate solid understanding of regulatory guidance and statistical methodology as applied to clinical studies in pharmaceutical development.
Writing statistical reports and memos with minimal guidance.
Validating complex datasets or summary tables.
Oversight CRO on statistical deliverables
Other duties as assigned.

Qualifications

Master's Degree in statistics, biostatistics or a closely related field; PhD preferred.

Celcuity is a commercial biotechnology company pursuing development of targeted therapies for treatment of multiple solid tumor indications.

The company's first FDA-approved product is REVTORPYK (gedatolisib), a potent, pan-PI3K and mTORC1/2 inhibitor that comprehensively blockades the PAM pathway.

REVTORPYK is approved to treat adults with HR+/HER2- advanced breast cancer that progressed on prior endocrine therapy in the metastatic setting.

The Phase 3 VIKTORIA-2 trial is evaluating gedatolisib in combination with palbociclib and either fulvestrant or letrozole for the first-line treatment of HR+/HER2- locally advanced or metastatic breast cancer.

A Phase 1/2 clinical trial evaluating gedatolisib in combination with darolutamide in patients with metastatic castration resistant prostate cancer, is ongoing.

Celcuity is an Equal-Opportunity Employer.

Celcuity is committed to fair and equitable compensation practices, and we strive to provide employees with total compensation packages that are competitive.

For this role, the anticipated base pay range is $195,000 to $215,000 DOE.

The exact base pay offered for this role will depend on various factors, including but not limited to the candidate’s geography, qualifications, skills, and experience.

The successful candidate will be eligible for an annual performance incentive bonus and a new hire equity package.

Celcuity also offers various benefits offerings, including, but not limited to, medical, dental, vision insurance, 401(k) match, PTO, and paid holidays.

Director, Biostatistics

Job Fit Check

Key Skills for This Role

Full Job Posting

Responsibilities

Qualifications

Apply for this job in 1 click

More jobs at Celcuity

Associate Director, Assay and Process Development

Bioinformatics Scientist

Senior or Principal Scientist, Formulation and Process Development

Manager, Post-Marketing Pharmacovigilance

Manager, Statistical Programming

Associate Director/Director of Pharmaceutical Development

Senior Manager/Associate Director, Commercial Supply Planning

Oncology Sales Specialist -Santa Monica, California